NDC 0409-6637 – Sodium Bicarbonate
Sodium Bicarbonate 84 mg/mL · Injection, Solution · Intravenous
Product NDC0409-6637
Product details
- Brand name
- Sodium Bicarbonate
- Generic name
- Sodium Bicarbonate
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA202494
- Marketed since
- July 23, 2020
- Marketing end
- November 30, 2026
- Pharmacologic class
- Osmotic Laxative
Active ingredients
- Sodium Bicarbonate 84 mg/mL
Uses, dosage, side effects and warnings for Sodium bicarbonate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-6637-14 | 10 CARTON in 1 PACKAGE (0409-6637-14) / 1 SYRINGE in 1 CARTON / 50 mL in 1 SYRINGE (0409-6637-24) | Jul 23, 2020 |
Recalls mentioning this NDC
- D-0591-2025 Aug 27, 2025 · Class II
Lack of Assurance of Sterility. - D-0234-2024 Jan 24, 2024 · Class I
Presence of Particulate Matter; identified as glass
Other Sodium bicarbonate products
- 50090-0530 Sodium Bicarbonate 84 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-6813 Sodium Bicarbonate 84 mg/mL · Injection, Solution · A-S Medication Solutions
- 80830-2305 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Amneal Pharmaceuticals Private Limited
- 80830-2613 Sodium Bicarbonate 12.6 mg/mL · Injection, Solution · Amneal Pharmaceuticals Private Limited
- 83854-001 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Anthea Pharma Private Limited
- 0338-0822 Sodium Bicarbonate 12.6 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 72162-2314 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Bryant Ranch Prepack
- 72572-740 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Civica
- 51754-5011 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC
- 51754-5012 Sodium Bicarbonate 42 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC
- 51754-8888 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC
- 51754-8020 Sodium Bicarbonate 84 mg/mL · Injection, Solution · Exela Pharma Sciences, LLC